Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ACETYLCYSTEINE Cause Interstitial lung disease? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Interstitial lung disease have been filed in association with ACETYLCYSTEINE (Acetylcysteine). This represents 0.4% of all adverse event reports for ACETYLCYSTEINE.

10
Reports of Interstitial lung disease with ACETYLCYSTEINE
0.4%
of all ACETYLCYSTEINE reports
1
Deaths
8
Hospitalizations

How Dangerous Is Interstitial lung disease From ACETYLCYSTEINE?

Of the 10 reports, 1 (10.0%) resulted in death, 8 (80.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.

Is Interstitial lung disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ACETYLCYSTEINE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does ACETYLCYSTEINE Cause?

Drug ineffective (428) Dyspnoea (297) Off label use (250) Acute kidney injury (224) Hypertension (216) Asthma (197) Chronic obstructive pulmonary disease (187) Productive cough (164) Wheezing (161) Toxicity to various agents (158)

What Other Drugs Cause Interstitial lung disease?

METHOTREXATE (3,049) RITUXIMAB (2,458) PEMBROLIZUMAB (2,113) PREDNISONE (1,850) CYCLOPHOSPHAMIDE (1,725) NIVOLUMAB (1,538) AMIODARONE (1,421) DOXORUBICIN (1,352) ETANERCEPT (1,267) ADALIMUMAB (1,250)

Which ACETYLCYSTEINE Alternatives Have Lower Interstitial lung disease Risk?

ACETYLCYSTEINE vs ACETYLLEUCINE ACETYLCYSTEINE vs ACETYLLEUCINE, L- ACETYLCYSTEINE vs ACETYLSALICYLIC ACID ACETYLCYSTEINE vs ACITRETIN ACETYLCYSTEINE vs ACLARUBICIN

Related Pages

ACETYLCYSTEINE Full Profile All Interstitial lung disease Reports All Drugs Causing Interstitial lung disease ACETYLCYSTEINE Demographics